Skip to main content
Livermore
Livermore
ZHEN

TCR2 Therapeutics Inc.

TCRRDelisted Jun 1, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001750019

TCR2 Therapeutics Inc. was delisted on Jun 1, 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.5M in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding TCR2 Therapeutics Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of TCRR: Q4 2021 compared with Q1 2022
MeasureQ4 2021Of which not filed for Q1 2022Q1 2022Change
Holders122194−27
Shares29.2M151.0K27.1M−1.91M (−6.6%)
Value$136.0M$704.0K$74.8M−$60.5M (−44.7%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held TCR2 Therapeutics Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to TCRR in Q1 2022
InstitutionSharesValue% of portfolio
Tang Capital Management LLC3,000,000$8.28M1.68%
Kennedy Capital Management, Inc.121,789$336.0K0.01%
Bridgeway Capital Management, LLC98,400$272.0K0.01%
LPL Financial LLC34,285$95.0K0.00%
Sawtooth Solutions, LLC31,530$87.0K0.01%
Nan Fung Group Holdings Ltd19,335$53.0K0.03%
Bayesian Capital Management, LP11,300$31.0K0.00%
Newman Dignan & Sheerar, Inc.11,023$30.0K0.01%
Amalgamated Bank3,672$10.0K0.00%
Amalgamated Financial Corp.3,672$10.0K0.00%
Plante Moran Financial Advisors, LLC900$2.00K0.00%
Capital Advisors, Ltd. LLC299$1.00K0.00%
Group One Trading, L.P.79$00.00%
Prospera Financial Services Inc100$00.00%

Sold out (41)

Institutions that held TCR2 Therapeutics Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of TCRR in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Wellington Management Group LLP835,327$3.89M
Point72 Asset Management, L.P.350,000$1.63M
Jacobs Levy Equity Management, Inc204,290$952.0K
Walleye Capital LLC203,554$949.0K
Trexquant Investment LP171,306$798.0K
HRT Financial LP163,097$760.0K
Nomura Holdings Inc128,977$604.0K
Anson Funds Management LP101,839$475.0K
Alberta Investment Management Corp100,000$466.0K
Susquehanna International Group, LLP77,501$361.0K
Marshall Wace, LLP68,493$320.0K
Jane Street Group, LLC63,142$294.0K
Dynamic Technology Lab Private Ltd58,275$272.0K
Jump Financial, LLC54,500$254.0K
Martingale Asset Management L P52,234$244.0K
Squarepoint Ops LLC41,925$195.0K
Graham Capital Management, L.P.40,611$189.0K
ExodusPoint Capital Management, LP37,024$173.0K
Virtu Financial LLC31,912$149.0K
Ensign Peak Advisors, Inc30,860$144.0K
Connor, Clark & Lunn Investment Management Ltd.28,760$134.0K
Algert Global LLC27,596$129.0K
Voloridge Investment Management, LLC26,773$125.0K
Gyon Technologies Capital Management, LP24,248$113.0K
Caxton Associates LP22,784$106.0K
SG Americas Securities, LLC22,569$105.0K
Walleye Trading LLC22,549$105.0K
IndexIQ Advisors LLC19,126$89.0K
Altshuler Shaham Ltd18,600$87.0K
Engineers Gate Manager LP15,837$74.0K
Manufacturers Life Insurance Company, The14,653$68.0K
ProShare Advisors LLC12,044$56.0K
UBS Group AG9,701$45.0K
Zurcher Kantonalbank (Zurich Cantonalbank)1,780$8.00K
Eagle Bay Advisors LLC1,133$5.00K
The PNC Financial Services Group, Inc.352$2.00K
Wagner Wealth Management, LLC366$2.00K
High Net Worth Advisory Group LLC500$2.00K
Tarbox Family Office, Inc.220$1.00K
Evoke Wealth, LLC295$1.00K
Parallel Advisors, LLC10$0

Not filed for Q1 2022 yet (1)

Institutions that held TCR2 Therapeutics Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TCRR in Q4 2021 that haven't filed for Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
AlphaCentric Advisors LLC151,000$704.0K